PredictImmune and KSL Diagnostics announce attendance at the Crohn’s & Colitis Congress

Cambridge, UK and Buffalo, NY, 10th January 2020

PredictImmune and US partner KSL Diagnostics are pleased to announce they will be attending the Crohn’s & Colitis Congress® from January 23-25, 2020 in Austin TX. The co-branded booth will be attended by both Predictimmune and KSL CEOs Paul Kinnon and Kevin Lawson, as the companies work toward the USA/Canada launch of PredictSURE® IBD, the first validated prognostic test for IBD.

The PredictImmune and KSL teams look forward to meeting you at Booth #629 in the Exhibition area at the Austin Convention Center. Booth topics will include discussions on how you can access PredictSURE IBD for your IBD patients. New information will also be available on the PRECIOUS study.

For more information, please see the KSL (https://www.ksldx.com/) website.

Booth 629:  PredictImmune Ltd & KSL Diagnostics

Austin Convention Center, Austin, TX

Gain a multidisciplinary perspective on treating inflammatory bowel diseases (IBD). Join health care professionals and researchers at the Crohn’s & Colitis Congress® for the premier conference on IBD. Discover different perspectives, leave with practical information you can immediately implement, and hear about potential treatments on the horizon.

This state-of-the-art educational event has been called a “must” for anyone treating patients with IBD.